WSBTV Narconon GA Part 3 2012-10-03

WSBTV Narconon GA Part 3 2012-10-03 – WSB TV Action News Atlanta, GA investigative report of the tragic death of Patrick Desomond in 2008. Whistleblower, memo link Georgia Narconon to Scientology Channel 2 Investigation looks at nonprofit rehab program after patient death By Jodie Fleischer ATLANTA — A worldwide drug treatment program that’s denied its affiliation with the Church of Scientology faces new scrutiny now that a whistleblower has come forward. Channel 2 Action News has uncovered documents which tie Narconon of Georgia to the controversial church. Channel 2 investigative reporter Jodie Fleischer obtained records that show the director of the Georgia program knew staff members were drinking and doing drugs with patients. A whistleblower told Fleischer the program was more focused on its image than fixing problems and the church uses Narconon to make money and recruit vulnerable addicts into Scientology. Lucas Catton told Flesicher he knows the Narconon drug treatment program better than almost anyone. He went through it as a student, and then rose to be become president of the Flagship Arrowhead facility in Oklahoma. “Is it what it pretends to be? Absolutely not,” said Catton. “Narconon is, essentially it is Scientology.” read more and follow at: www.wsbtv.com

Lilly, Roche Drugs Chosen for Alzheimer Prevention Trial

Filed under: drug treatment news 2012

Alzheimer's drugs from Eli Lilly & Co. (LLY) and Roche Holding AG were selected for a long-term study that, if successful, may lead to the treatments being used as a deterrent for people with a family history of the disease. The experimental medicines …
Read more on Businessweek

AIDS fighters fear trade deal

Filed under: drug treatment news 2012

The cost of treating one AIDS patient for one year, she said, has declined from an average of $ 10,000 in 2000, when doctors relied mainly on brand-name drugs, to $ 150 in 2012, now that generics have driven prices down. On the opposite side, Sam Taylor, …
Read more on News & Observer